We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
Read MoreHide Full Article
Key Takeaways
on! shipments jumped 18% to 39.3M cans in Q1 2025, bucking declines in MO's oral tobacco portfolio.
on! grew total oral tobacco market share to 8.8% and pouch segment share to 17.9% despite rising competition.
Helix boosted on! brand awareness to over 60% via its "It's On!" campaign and targeted retail investments.
Altria Group, Inc.’s (MO - Free Report) on! nicotine pouch brand continues to outperform in an increasingly competitive marketplace, serving as a rare growth engine within its oral tobacco segment. While traditional brands like Copenhagen and Skoal posted double-digit volume declines in the first quarter of 2025, on! defied the trend, growing shipments by 18% to 39.3 million cans. This performance highlights the accelerating consumer shift toward nicotine pouches, which now represent 49.1% of the total U.S. oral tobacco category, an increase of 8.7 share points compared with the prior year.
on!’s share of the total oral tobacco market rose to 8.8%, a gain of 1.8 share points year over year and increased its nicotine pouch segment share to 17.9%, up 0.5 share points despite intensifying competition. Notably, Helix, a leading manufacturer of oral nicotine pouches, which manages the on! brand. Helix achieved this growth while raising retail prices and optimizing promotional spending, a clear sign of strengthening brand equity and loyalty among consumers.
Backed by the “It’s On!” campaign, Helix increased consumer impressions of on! by nearly five times compared with the prior year. Brand awareness among current nicotine pouch users rose to more than 60%, marking a 9-percentage point gain from the previous year. Looking ahead, Helix aims to maintain this momentum by broadening the campaign’s reach and deepening brand equity investments across both new and existing retail channels.
In short, on! is not just a growth contributor, the brand is the centerpiece of Altria’s oral tobacco strategy, serving as its primary vehicle for navigating the industry’s shift toward modern nicotine products.
MO Faces Rising Competition in Nicotine Pouches
In the U.S. nicotine pouch category, Philip Morris International (PM - Free Report) continues to lead with its flagship brand ZYN. In the first quarter of 2025, Philip Morris’ ZYN shipped more than 200 million cans, representing a 63% increase year over year, driven by robust consumer demand and expanded production capacity. Despite ongoing supply constraints and restocking efforts, Philip Morris maintained ZYN’s dominant retail share, holding more than 70% of category value.
Turning Point Brands (TPB - Free Report) is also expanding rapidly in the nicotine pouch space with its FRE and ALP brands. In the first quarter of 2025, Turning Point Brands reported $22.3 million in modern oral revenues, nearly a tenfold increase from the prior year. Turning Point Brands raised its full-year nicotine pouch sales forecast to $80-$95 million, indicating increased consumer adoption, broader market penetration and expanding commercial initiatives.
MO’s Price Performance, Valuation & Estimates
Shares of Altria have lost 2.6% in the past month compared with the industry’s decline of 0.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.8X, down from the industry’s average of 15.21X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 4.9% and 3.1%, respectively.
Image: Bigstock
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
Key Takeaways
Altria Group, Inc.’s (MO - Free Report) on! nicotine pouch brand continues to outperform in an increasingly competitive marketplace, serving as a rare growth engine within its oral tobacco segment. While traditional brands like Copenhagen and Skoal posted double-digit volume declines in the first quarter of 2025, on! defied the trend, growing shipments by 18% to 39.3 million cans. This performance highlights the accelerating consumer shift toward nicotine pouches, which now represent 49.1% of the total U.S. oral tobacco category, an increase of 8.7 share points compared with the prior year.
on!’s share of the total oral tobacco market rose to 8.8%, a gain of 1.8 share points year over year and increased its nicotine pouch segment share to 17.9%, up 0.5 share points despite intensifying competition. Notably, Helix, a leading manufacturer of oral nicotine pouches, which manages the on! brand. Helix achieved this growth while raising retail prices and optimizing promotional spending, a clear sign of strengthening brand equity and loyalty among consumers.
Backed by the “It’s On!” campaign, Helix increased consumer impressions of on! by nearly five times compared with the prior year. Brand awareness among current nicotine pouch users rose to more than 60%, marking a 9-percentage point gain from the previous year. Looking ahead, Helix aims to maintain this momentum by broadening the campaign’s reach and deepening brand equity investments across both new and existing retail channels.
In short, on! is not just a growth contributor, the brand is the centerpiece of Altria’s oral tobacco strategy, serving as its primary vehicle for navigating the industry’s shift toward modern nicotine products.
MO Faces Rising Competition in Nicotine Pouches
In the U.S. nicotine pouch category, Philip Morris International (PM - Free Report) continues to lead with its flagship brand ZYN. In the first quarter of 2025, Philip Morris’ ZYN shipped more than 200 million cans, representing a 63% increase year over year, driven by robust consumer demand and expanded production capacity. Despite ongoing supply constraints and restocking efforts, Philip Morris maintained ZYN’s dominant retail share, holding more than 70% of category value.
Turning Point Brands (TPB - Free Report) is also expanding rapidly in the nicotine pouch space with its FRE and ALP brands. In the first quarter of 2025, Turning Point Brands reported $22.3 million in modern oral revenues, nearly a tenfold increase from the prior year. Turning Point Brands raised its full-year nicotine pouch sales forecast to $80-$95 million, indicating increased consumer adoption, broader market penetration and expanding commercial initiatives.
MO’s Price Performance, Valuation & Estimates
Shares of Altria have lost 2.6% in the past month compared with the industry’s decline of 0.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.8X, down from the industry’s average of 15.21X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 4.9% and 3.1%, respectively.
Image Source: Zacks Investment Research
Altria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.